Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use

This key economic indicator for the Pharmaceutical sector has been recently updated.

  1. Portugal grew 10.5% of Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use in 2019, from a year earlier.
  2. Since 2014 Iceland Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use grew 4.9% year on year at 110.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day.
  3. In 2019 Netherlands was number 1 in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use.

Top Countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use

Source: OECD

Go Top